Framingham Heart Study: Generations of Genomes and the Factors Increasing Cardiovascular Risk (Secondary Data Analysis of BioLINCC Assession No. HLB00050025a)

Secondary analysis of longitudinal Framingham data, with planned integration of genomic data, to identify and validate biomarker and risk-factor patterns associated with cardiovascular disease incidence and progression using regression, survival analysis, and machine learning.

BioLINCC program of the National Heart, Lung, and Blood Institutes of the National Institutes of Health